We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATHX
2001
DELISTED
Athersys, Inc. Common Stock
ATHX
$10K ﹤0.01%
340
BPFH
2002
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
$10K ﹤0.01%
877
+396
+82% +$4.59K
MNK
2003
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$10K ﹤0.01%
3,217
TIVO
2004
DELISTED
Tivo Inc
TIVO
$10K ﹤0.01%
1,205
+447
+59% +$3.53K
SRCI
2005
DELISTED
SRC Energy Inc
SRCI
$10K ﹤0.01%
2,504
+1,099
+78% +$4.17K
BSBR icon
2006
Santander
BSBR
$41B
$9K ﹤0.01%
860
CIG icon
2007
CEMIG Preferred Shares
CIG
$6.21B
$9K ﹤0.01%
5,623
CMRE icon
2008
Costamare
CMRE
$1.86B
$9K ﹤0.01%
+1,001
New +$7.99K
ECPG icon
2009
Encore Capital Group
ECPG
$2.06B
$9K ﹤0.01%
269
+86
+47% +$3.01K
EHC icon
2010
Encompass Health
EHC
$11.5B
$9K ﹤0.01%
175
EWU icon
2011
iShares MSCI United Kingdom ETF
EWU
$4.09B
$9K ﹤0.01%
278
-1,626
-85% -$52.9K
GEF icon
2012
Greif
GEF
$4.74B
$9K ﹤0.01%
222
HAIN icon
2013
Hain Celestial
HAIN
$44.8M
$9K ﹤0.01%
384
+134
+54% +$3.2K
HFWA icon
2014
Heritage Financial
HFWA
$1.22B
$9K ﹤0.01%
331
+170
+106% +$4.69K
HOUS
2015
DELISTED
Anywhere Real Estate
HOUS
$9K ﹤0.01%
1,017
+329
+48% +$3.02K
IBP icon
2016
Installed Building Products
IBP
$6.47B
$9K ﹤0.01%
138
+53
+62% +$3.58K
IDCC icon
2017
InterDigital
IDCC
$6.72B
$9K ﹤0.01%
166
+31
+23% +$1.71K
IRT icon
2018
Independence Realty Trust
IRT
$3.93B
$9K ﹤0.01%
696
+263
+61% +$3.83K
LAUR icon
2019
Laureate Education
LAUR
$5.28B
$9K ﹤0.01%
+538
New +$8.86K
LGIH icon
2020
LGI Homes
LGIH
$1.43B
$9K ﹤0.01%
137
+50
+57% +$3.81K
LNTH icon
2021
Lantheus
LNTH
$6.68B
$9K ﹤0.01%
481
+127
+36% +$2.57K
MTCH icon
2022
Match Group
MTCH
$9.16B
$9K ﹤0.01%
124
+39
+46% +$2.84K
MTX icon
2023
Minerals Technologies
MTX
$2.33B
$9K ﹤0.01%
165
+101
+158% +$5.43K
MXE
2024
Mexico Equity and Income Fund
MXE
$58.5M
$9K ﹤0.01%
+862
New +$9.47K
OGS icon
2025
ONE Gas
OGS
$5.06B
$9K ﹤0.01%
97
+43
+80% +$3.93K

Similar funds

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.